Likewise, FUNDC1 deficiency was shown to promote obesity, insulin resistance, MetS, cardiac remodeling, and even cell death due to defective control of mitochondrial quality (Wu et al., 2019a; Ren et al., 2020). This evidence concerns the gene FUNDC1 and metabolic syndrome.